Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.76 USD | +0.92% | +4.85% | +5.11% |
May. 08 | Transcript : PetIQ, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
May. 08 | Earnings Flash (PETQ) PETIQ Reports Q1 Revenue $308.4M, vs. Street Est of $300.4M | MT |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Sales forecast by analysts have been recently revised upwards.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company sustains low margins.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Pharmaceuticals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+5.11% | 613M | C+ | ||
-14.09% | 77.37B | B+ | ||
+18.66% | 8.74B | B- | ||
+23.75% | 3.67B | B- | ||
-0.42% | 3.25B | B- | ||
+18.07% | 1.73B | - | ||
-16.99% | 1.38B | B | ||
-26.05% | 1.24B | C- | ||
-17.86% | 1.07B | - | ||
-6.77% | 976M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- PETQ Stock
- Ratings PetIQ, Inc.